| Product Code: ETC7332101 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ghana Multiple Sclerosis Drugs Market Overview |
3.1 Ghana Country Macro Economic Indicators |
3.2 Ghana Multiple Sclerosis Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Ghana Multiple Sclerosis Drugs Market - Industry Life Cycle |
3.4 Ghana Multiple Sclerosis Drugs Market - Porter's Five Forces |
3.5 Ghana Multiple Sclerosis Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Ghana Multiple Sclerosis Drugs Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Ghana Multiple Sclerosis Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Ghana Multiple Sclerosis Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ghana Multiple Sclerosis Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about multiple sclerosis (MS) and its treatment options in Ghana |
4.2.2 Growing prevalence of MS cases in Ghana |
4.2.3 Rising healthcare expenditure and improved access to healthcare services in the country |
4.3 Market Restraints |
4.3.1 Limited availability of advanced MS treatment options in Ghana |
4.3.2 High cost associated with MS drugs and therapies |
4.3.3 Lack of specialized healthcare professionals for MS management in the country |
5 Ghana Multiple Sclerosis Drugs Market Trends |
6 Ghana Multiple Sclerosis Drugs Market, By Types |
6.1 Ghana Multiple Sclerosis Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Ghana Multiple Sclerosis Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Ghana Multiple Sclerosis Drugs Market Revenues & Volume, By Interferon Beta, 2021- 2031F |
6.1.4 Ghana Multiple Sclerosis Drugs Market Revenues & Volume, By Mixed Polymers, 2021- 2031F |
6.1.5 Ghana Multiple Sclerosis Drugs Market Revenues & Volume, By NF-kB Inhibitor, 2021- 2031F |
6.1.6 Ghana Multiple Sclerosis Drugs Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.7 Ghana Multiple Sclerosis Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ghana Multiple Sclerosis Drugs Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Ghana Multiple Sclerosis Drugs Market Revenues & Volume, By Relapsng-remitting MS (RRMS), 2021- 2031F |
6.2.3 Ghana Multiple Sclerosis Drugs Market Revenues & Volume, By Primar-progressive MS (PPMS), 2021- 2031F |
6.2.4 Ghana Multiple Sclerosis Drugs Market Revenues & Volume, By Secondary-progressive MS (SPMS), 2021- 2031F |
6.2.5 Ghana Multiple Sclerosis Drugs Market Revenues & Volume, By Progressive-relapsng MS (PRMS), 2021- 2031F |
6.3 Ghana Multiple Sclerosis Drugs Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Ghana Multiple Sclerosis Drugs Market Revenues & Volume, By Prenteral, 2021- 2031F |
6.3.3 Ghana Multiple Sclerosis Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.4 Ghana Multiple Sclerosis Drugs Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Ghana Multiple Sclerosis Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Ghana Multiple Sclerosis Drugs Market Revenues & Volume, By Retail Pharmacies & Drug Stores, 2021- 2031F |
6.4.4 Ghana Multiple Sclerosis Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Ghana Multiple Sclerosis Drugs Market Import-Export Trade Statistics |
7.1 Ghana Multiple Sclerosis Drugs Market Export to Major Countries |
7.2 Ghana Multiple Sclerosis Drugs Market Imports from Major Countries |
8 Ghana Multiple Sclerosis Drugs Market Key Performance Indicators |
8.1 Number of MS awareness campaigns and educational programs conducted in Ghana |
8.2 Percentage increase in the diagnosis rate of MS patients in Ghana |
8.3 Number of new MS drugs or therapies approved for use in the Ghanaian market |
9 Ghana Multiple Sclerosis Drugs Market - Opportunity Assessment |
9.1 Ghana Multiple Sclerosis Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Ghana Multiple Sclerosis Drugs Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Ghana Multiple Sclerosis Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Ghana Multiple Sclerosis Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ghana Multiple Sclerosis Drugs Market - Competitive Landscape |
10.1 Ghana Multiple Sclerosis Drugs Market Revenue Share, By Companies, 2024 |
10.2 Ghana Multiple Sclerosis Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here